|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0320 USD | -1.54% |
|
-1.54% | +60.00% |
| Market Cap | 5.07M 3.58M 3.13M 2.89M 2.67M 341M 5.15M 34.56M 13.55M 168M 13.43M 13.14M 581M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.68M 5.84M 5.39M 4.99M 638M 9.62M 64.55M 25.3M 313M 25.08M 24.54M 1.08B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.54% | ||
| 1 week | -1.54% | ||
| Current month | -1.54% | ||
| 3 months | +16.36% | ||
| 6 months | +7.38% | ||
| Current year | +60.00% |
| 1 week | 0.03 | 0.03 | |
| 1 month | 0.01 | 0.04 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.18 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 2017-09-21 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 2015-03-09 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 2018-05-16 |
Benjamin Higham
BRD | Director/Board Member | - | 2020-04-07 |
Jakob Ripshtein
BRD | Director/Board Member | 59 | 2020-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-12-16 | Buy | Director | 30,000 | 0.0274% | ||
| 23-12-16 | Buy | Director | 500 | 0.0005% | ||
| 23-12-16 | Buy | Director | 30,000 | 0.0274% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.54% | -1.54% | -0.62% | -82.92% | 3.57M | ||
| -3.15% | -6.03% | +25.68% | -8.16% | 1.62B | ||
| +1.04% | -7.12% | +49.23% | +268.57% | 978M | ||
| +0.32% | -2.48% | -1.87% | +93.25% | 195M | ||
| -7.43% | -10.00% | +72.34% | -64.78% | 191M | ||
| -1.33% | -4.19% | +15.12% | -44.28% | 85.59M | ||
| Average | -2.02% | -5.00% | +26.65% | +26.95% | 511.26M | |
| Weighted average by Cap. | -1.81% | -6.81% | +34.02% | +81.84% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 9.74M 8.52M 7.86M 7.27M 930M 14.03M 94.09M 36.88M 456M 36.56M 35.77M 1.58B | 14.25M 10.06M 8.8M 8.11M 7.51M 960M 14.49M 97.17M 38.09M 471M 37.76M 36.94M 1.63B |
| Net income | -1.49M -1.05M -922K -850K -786K -101M -1.52M -10.18M -3.99M -49.38M -3.95M -3.87M -171M | -2.69M -1.9M -1.66M -1.53M -1.42M -181M -2.74M -18.35M -7.19M -89.02M -7.13M -6.98M -308M |
| Net Debt | 5.66M 3.99M 3.49M 3.22M 2.98M 381M 5.75M 38.58M 15.12M 187M 14.99M 14.67M 648M | 4.4M 3.1M 2.72M 2.5M 2.32M 296M 4.47M 29.99M 11.76M 146M 11.65M 11.4M 504M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-09 | US$0.0320 | -1.54% | 26,090 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















